Psoriasiform Dermatitis in a COVID-19 Patient

Psoriasis is a chronic inflammatory papulosquamous disorder which affects around 2% of the world's population. A peak exacerbation in psoriatic symptoms was noted during COVID-19 due to lack of access to dermatological care mixed with heightened emotional stress during the pandemic. This case r...

Full description

Saved in:
Bibliographic Details
Main Authors: Marlyn Wu (Author), Shereen Teymour (Author), Robin Ashinoff (Author), Hira Ghani (Author)
Format: Book
Published: Hindawi Limited, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_628885bca16b44b480e6522e2acb5d86
042 |a dc 
100 1 0 |a Marlyn Wu  |e author 
700 1 0 |a Shereen Teymour  |e author 
700 1 0 |a Robin Ashinoff  |e author 
700 1 0 |a Hira Ghani  |e author 
245 0 0 |a Psoriasiform Dermatitis in a COVID-19 Patient 
260 |b Hindawi Limited,   |c 2022-01-01T00:00:00Z. 
500 |a 2090-6471 
500 |a 10.1155/2022/1820673 
520 |a Psoriasis is a chronic inflammatory papulosquamous disorder which affects around 2% of the world's population. A peak exacerbation in psoriatic symptoms was noted during COVID-19 due to lack of access to dermatological care mixed with heightened emotional stress during the pandemic. This case report describes a 52-year-old admitted male patient who sustained a diffuse rash on multiple areas of his body a week prior to testing positive for COVID-19. We explore plausible causes for the occurrence of the rash, discuss our treatment plan, include relevant clinical pictures, and review published literature to examine conditions that present similarly to the rash seen in our patient. It is crucial for dermatologists to be able to discern various systemic manifestations associated with cutaneous lesions, such as the one seen in this patient, in order to make an accurate and prompt diagnosis. A better understanding of the association between COVID-19 infection and psoriasiform lesions is needed for improving the prognostic and therapeutic outcomes in patients. 
546 |a EN 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Case Reports in Dermatological Medicine, Vol 2022 (2022) 
787 0 |n http://dx.doi.org/10.1155/2022/1820673 
787 0 |n https://doaj.org/toc/2090-6471 
856 4 1 |u https://doaj.org/article/628885bca16b44b480e6522e2acb5d86  |z Connect to this object online.